Video Experimental Relacionado
Updated: May 6, 2026
15:23
Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
Published on: May 13, 2010
19.7K
Dirigirse a la interacción proteína-proteína APP-Mint2 con un inhibidor basado en péptidos reduce la formación de
Christian R O Bartling1,2, Thomas M T Jensen1, Shawna M Henry2
1Department of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 162, DK-2100 Copenhagen, Denmark.
Journal of the American Chemical Society
|January 5, 2021
Resumen
La proteína Mint2 facilita la producción de beta amiloide (Aβ) en la enfermedad de Alzheimer (EA). Dirigirse a esta interacción con inhibidores o métodos genéticos ofrece una estrategia terapéutica prometedora para la EA.
Área de la Ciencia:
- La neurociencia
- Biología molecular
- Descubrimiento de drogas
Sus antecedentes:
- La enfermedad de Alzheimer (EA) requiere urgentemente nuevos tratamientos para controlar los síntomas y detener la progresión.
- La acumulación de péptido amiloide-beta (Aβ), a partir de la escisión de la proteína precursora amiloide (APP), caracteriza la enfermedad de Alzheimer.
- Se ha debatido el papel de la proteína Mint2 en la generación de Aβ, con informes contradictorios sobre su efecto.
Objetivo del estudio:
- Aclarar el papel de Mint2 en el procesamiento de la proteína precursora amiloide (APP) y la generación de Aβ.
- Investigar la interacción proteína-proteína (IPP) entre APP y Mint2.
- Desarrollar nuevas estrategias terapéuticas dirigidas a la interacción APP-Mint2.
Principales métodos:
- Análisis detallado de la interacción proteína-proteína (PPI) de APP-Mint2 a través de la prueba de enlace H de la columna vertebral y de la interacción de la cadena lateral.
- Desarrollo de un inhibidor de péptidos estable y de alta afinidad para la interacción APP-Mint2.
- Utilización de un modelo neuronal in vitro de la enfermedad de Alzheimer para evaluar los niveles de Aβ.
Principales resultados:
- El estudio aclaró las interacciones específicas entre APP y Mint2.
- Un inhibidor de péptido permeable a las células dirigido al IPP de APP-Mint2 redujo significativamente los niveles de Aβ42.
- Una variante Mint2 con deficiencia de unión a la APP también condujo a una disminución de los niveles de Aβ42 in vitro.
Conclusiones:
- Mint2 juega un papel facilitador en la formación de péptidos Aβ patógenos.
- Dirigirse a la proteína Mint2, a través de medios genéticos o farmacológicos, presenta una vía terapéutica viable para reducir los niveles de Aβ en la enfermedad de Alzheimer.
- Esta investigación proporciona una base para el desarrollo de nuevas terapias para la enfermedad de Alzheimer.
Más Videos Relacionados
06:40Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
Published on: January 25, 2018
7.0K
06:17A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
12.3K
Videos de Conceptos Relacionados
00:46Feedback Inhibition
44.2K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
44.2K
01:19Allosteric Proteins-ATCase
4.9K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
4.9K
01:23Antimicrobial Proteins
10.7K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.7K
01:24Phase II Reactions: Acetylation Reactions
1.1K
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
1.1K
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
958
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
958
01:18Amino Acid Catabolism
1.8K
Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
1.8K